ASE Technology Holding Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 delivered strong year-over-year growth in revenue and profit, led by robust ATM and LEAP services performance, while EMS faced expected seasonal softness. CapEx was raised to support LEAP expansion, with further growth and margin improvement expected in the second half.
Fiscal Year 2025
-
Revenue and profit surged in 2025, led by strong ATM and LEAP business growth, with margins expanding on higher utilization and favorable product mix. 2026 outlook is robust, with aggressive CapEx planned to meet AI-driven demand and further margin improvement expected.
-
Third quarter results exceeded expectations with strong growth in both ATM and EMS, driven by high utilization and robust AI-related demand. Margins improved despite FX headwinds, and full-year ATM revenue is set to grow over 20% in USD terms.
-
Q2 2025 saw 7% year-over-year revenue growth and strong momentum in advanced packaging and testing, despite margin pressure from NT dollar appreciation. CapEx is being accelerated to meet robust AI-driven demand, with confidence in returning to structural margins in 2026.
-
Q1 saw strong year-over-year growth in revenues and margins, led by advanced packaging and test services, with robust AI-driven demand. Q2 guidance anticipates further ATM growth and margin expansion, while EMS faces seasonal softness. CapEx and margin targets for 2025 remain unchanged.
Fiscal Year 2024
-
Revenues grew 2% in 2024, led by strong gains in leading-edge advanced packaging and testing, with further acceleration and significant CapEx planned for 2025. Margins improved modestly, and the company is investing heavily to support AI-driven demand and smart factory expansion.
-
Third quarter results showed sequential and annual growth in revenue and profit, driven by leading-edge advanced packaging and strong test business momentum. Capital expenditures are rising to support future growth, with leading-edge revenues expected to more than double in 2025.
-
Q2 2024 saw strong growth in leading-edge products and investments, while traditional segments lagged. Revenue and margins improved sequentially, but full-year growth is now expected to be moderate due to slower market recovery. Leading-edge packaging and test revenue is set to double this year and next.